Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Letters|February 19, 2002
Loss of heterozygosity on chromosome 11 in esophageal squamous cell carcinomasChi Tat Lam, Cecilia Man Ching Tang, Kwok Wai Lau, et al.
Plos One|May 9, 2017
Succinct workflows for circulating tumor cells after enrichment: From systematic counting to mutational profilingVictor Chun-Lam Wong, Josephine Mun-Yee Ko, Chi-Tat Lam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2011
Brain-derived neurotrophic factor promotes tumorigenesis via induction of neovascularization: implication in hepatocellular carcinomaChi-Tat Lam, Zhen-Fan Yang, Chi-Keung Lau, et al.
Biochemical and Biophysical Research Communications|August 22, 2006
Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2)Chi Keung Lau, Zhen Fan Yang, Chi Tat Lam, et al.
Cancer Letters|October 1, 2008
Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinomaKa Ho Tam, Zhen Fan Yang, Chi Keung Lau, et al.
Journal of Cancer|June 21, 2021
Hallmark microRNA signature in liquid biopsy identifies hepatocellular carcinoma and differentiates it from liver metastasisVictor Chun-Lam Wong, Ming-In Wong, Chi-Tat Lam, et al.
International Immunology|September 15, 2005
Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophagesZhen Fan Yang, David W Ho, Chi Keung Lau, et al.
Biochemical and Biophysical Research Communications|June 20, 2006
Platelet activation during tumor development, the potential role of BDNF-TrkB autocrine loopZhen Fan Yang, David W Ho, Chi Keung Lau, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 31, 2007
Induction of long-term liver allograft survival by delayed immunosuppression is dependent on interleukin-10Zhen Fan Yang, Patricia Ngai, Chi Keung Lau, et al.
Molecular Cancer Therapeutics|September 21, 2006
High doses of tyrosine kinase inhibitor PTK787 enhance the efficacy of ischemic hypoxia for the treatment of hepatocellular carcinoma: dual effects on cancer cell and angiogenesisZhen Fan Yang, Ronnie T P Poon, Yuqing Liu, et al.
Pageof 2